Normal Human IgD+IgM− Germinal Center B Cells Can Express Up to 80 Mutations in the Variable Region of Their IgD Transcripts  by Liu, Yong-Jun et al.
Immunity, Vol. 4, 603±613, June, 1996, Copyright 1996 by Cell Press
Normal Human IgD1IgM2 Germinal Center
B Cells Can Express Up to 80 Mutations in
the Variable Region of Their IgD Transcripts
Yong-Jun Liu, Odette de Bouteiller, following: changes in the regulation of cell cycle control
genes, which lead to a high rate of clonal expansion ofChristophe Arpin, Francine BrieÁ re,
antigen-specific B cells (Kroese et al., 1987; Jacob etLaurent Galibert, Stephen Ho,
al., 1991a; Liu et al., 1991); introduction of somatic pointHector Martinez-Valdez, Jacques Banchereau,
mutations into IgV region genes during the course ofand Serge Lebecque
clonal expansion (Manser et al., 1985; Berek et al., 1991;Schering-Plough
Jacob et al., 1991b; KuÈ ppers et al., 1993; McHeyzer-Laboratory for Immunological Research
Williams et al., 1993; Pascual et al., 1994); changes in27 chemin des Peupliers, BP11
the expression of survival/death genes that make the69571, Dardilly Cedex
somatic mutated cells prone to die unless selected byFrance
antigens (Liu et al., 1989); isotype switch of IgH chain
constant region genes (Kraal et al., 1982; Feuillard et
al., 1995; Liu et al., 1996). To date, both the molecularSummary
mechanisms and the stage-specific progression of
these genetic events remain largely unknown. Using anSomatic hypermutation in immunoglobulin variable re-
approach similar to the study of primary B and T cell
gion genes occurs within germinal centers. Here, we
development in the bone marrow and in the thymus,
describe a subset of germinal center dark zone respectively, human tonsillar B cells representing five
centroblasts that express only sIgD and have accumu- distinct differentiation stages were previously isolated
lated up to 80 mutations per heavy chain variable re- according to surface markers (Liu et al., 1994; Pascual
gion (IgVHd gene). Over half of the hypermutated IgVHd et al., 1994). These include two naive B cell subsets,
sequences were found to be clonally related. This level sIgD1CD382CD232 (Bm1) and sIgD1CD382CD231
of mutation is not observed in either IgVHg transcripts (Bm2); two GC B cell subsets, sIgD2CD381CD771
from the same sample or IgVHd transcripts from pe- centroblasts (Bm3) and sIgD2CD381CD772 centrocytes
ripheral blood, suggesting that these cells neither un- (Bm4); and a sIgD2CD382 memory (Bm5) subset (Liu et
dergo isotype switch nor mature into circulating mem- al., 1995). Our previous studies based on these five hu-
ory B cells. Optimal growth of these cells in vitro man B cell subsets have concluded that, first, the molec-
depends on CD40 ligand, T cell cytokines, and a fibro- ular events underlying somatic mutation occur during
blast stroma, a combination possibly mimicking the the transition from the Bm2 subset into the centroblast
dark zone microenvironment. Our hypothesis is that (Bm3) subset (Pascual et al., 1994); second, that within
these cells may be sequestered within germinal cen- human tonsillar GCs, isotype switch is triggered within
ters, where their somatic mutation machinery is trig- centrocytes (Bm4), as indicated by the expression of
gered. The isolation of these hypermutated B cells sterile Ig, Ia, and Ie transcripts (Liu et al., 1996); third,
that the high proliferation rate and death propensity ofmay represent a critical step for studying both the
GC centroblasts (Bm3) and centrocytes (Bm4) correlatebiology and biochemistry of somatic hypermutation.
with their high expression of apoptosis-inducing genes
like c-myc, p53, Bax, and Fas in the absence of bcl-2Introduction
(Martinez-Valdez et al., 1996).
The mechanisms controlling somatic hypermutationThe immune system of vertebrates does not forget an
within IgV genes remain largely unknown (Neubergerantigenic insult. This memory of the immune system is
and Milstein, 1994; Weill and Reynaud, 1996), partly be-
borne by memory B and T lymphocytes, which make
cause of the unavailability of a cell population displaying
rapid and robust humoral (antibody) or cell-mediated
high somatic mutation activity (Maizels, 1995). Thus,
responses upon subsequent antigenic invasion. The
obtaining sufficient starting material at a stage during
generation of memory B lymphocytes from naive B lym- GC development at which B cells hypermutate their IgV
phocytes occurs within the secondary lymphoid tissues. genes will be critical in allowing the study of both the
Naive B lymphocytes that carry low affinity surface im- biology and biochemistry of this phenomenon. In this
munoglobulin M (IgM) and IgD antigen receptors can be article, we report a novel human tonsillar B cell subset
induced to secrete mainly low affinity IgM antibodies defined by a sIgM2IgD1CD381 phenotype. These cells
following primary antigen encounter. However, some of have accumulated the highest number of mutations
the antigen-activated naive B cells also undergo a series within their IgVH genes ever reported in normal B cells.
of developmental genetic eventswithin germinal centers Additionally, we present evidence suggesting that these
(GCs) (Kroese et al., 1990; Liu et al., 1992; Nossal, 1992; cells represent centroblasts that are trapped within the
MacLennan, 1994; Thorbecke et al., 1994; Weissman, GC dark zone, where their somatic mutation machinery
1994; Liu and Banchereau, 1996), which lead to the is likely to be triggered repeatedly.
emergence of memory B lymphocytes carrying antigen
receptors with high affinity antigen-binding domains Results
(CDRs) (Rajewsky, 1989; Vitetta et al., 1991; Weiss et
al., 1992; Berek, 1993; Gray, 1993; Sprent, 1994). These A Population of sIgD1CD381 Tonsillar B
receptors may be expressed in the context of g, a, or e Cells Expresses Many GC Markers
constant regions, in addition to d (Coffman et al., 1993; A B cell subpopulation coexpressing sIgD and sCD38
represents 5%±15% of total tonsillar B cells (Figure 1A).Klein et al., 1994). These genetic events include the
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Figure 1. Identification of sIgD1CD381 Tonsillar B Cells
(A) Double staining of total tonsil B cells with anti-IgD±PE and anti-CD38±FITC, showing four B cell subsets. The sIgD1CD381 B cells represent
5%±15% of total tonsil B cells from more than 30 samples analyzed to date.
(B) Phenotypic analysis by three-color flow cytometry. Anti-IgD±tricolor and anti-CD38±PE are used together with other third antibodies directly
conjugated with FITC. Anti-IgD±PE and anti-CD38±FITC were used together with Hoechst 33342. For Bcl-2 and Ki67 staining, the cells were
permeabilized by saponin (0.33 g/100 ml in PBS 1% BSA) for 15 min on ice.
sIgD1CD381 B cells display the GC markers CD10, sequences from sIgD1CD381 GC B cells, 11 were germ-
line (0.06/100 bp), 5 slightly mutated (1.6/100 bp), andCD71, and CD77 and express reduced levels of the naive
B cell markers CD23 and CD44 (Figure 1B) (Liu et al., 16 highly mutated (10.8/100 bp; Figure 3, center). Nine
sequences from three separate clones (clones 4b.1,1992; MacLennan, 1994; Thorbecke et al., 1994). About
70% of these cells express the proliferation-associated 4b.4, and 4b910) had accumulated 47±57 mutations per
transcript.nuclear antigen Ki67, half of them being in S/G2M phase.
They do not express Bcl-2 but all express FAS/CD95.
Based on sIgM, they can be divided into sIgM1 and The Hypermutated sIgD1CD381 B Cells
sIgM2 subpopulations (Figure 1B). Do Not Express sIgM
sIgD1CD381 GC B cells can be separated into a sIgM1
Many sIgD1CD381 B Cells Have Accumulated and a sIgM2 subset (see Figure 1B). From a third tonsil
the Highest Number of Mutations in IgVH sample, 12 VH5-d sequences from thesIgM1 subset were
Region Genes Ever Reported found to be in germline configuration (0.1/100 bp; data
in Normal B Cells not shown), while 9 of 10 VH5-d sequences from the
The mutation status of sIgD1CD381 B cells was deter- sIgM2 subset had accumulated 36±77 mutations per
mined by sequencing their VH5-d transcripts, together sequence (12.7/100 bp; Figure 4, left). Again, five hyper-
with VH5-d genes from sIgD1CD382 naive B cells and mutated VH5-d sequences (6c.1, 6c.3, 6c.7, 6c.9, 6c.10)
VH5-g genes from sIgD2CD381 GC B cells. No VH5-g are clonally related. The absence of stop codons in the
transcript could be amplified from the sIgD1CD381 B VH5-d sequences as well as the conservation of cys22
cells (Figure 2), confirming that they have not switched. and cys92, which are both involved in the formation of
Consistent with our recent report (Pascual et al., 1994), intrachain disulfide bond, were expected, since these
VH5 genes from IgD1CD382 naive Bcells have a mutation cells had been sorted based on surface immunoglobulin
frequency (0.19/100 bp; Figure 3, left) that is barely dis- expression.
tinguishable from the frequency of Taq errors (0.1/100
bp), while VH5-g genes from IgD2CD381 GC B cells were Hypermutated VH5-d Sequences
mutated (4.1/100 bp; Figure 3, right). Among 32 VH5-d Are Frequently Clonally Related
Of 31 hypermutated VH5-d sequences from the three
tonsil samples, 18 can be grouped into five independent
clones (clones 5.1, 5.3, 4b.1, 4b.4, and 6c.1; see Figure
3; Figure 4). The clonal trees deduced from the se-
quences of the two largest hypermutated clones, 4b.1
and 6c.1 (see Figures 3 and 4; Figures 5A and 5B),
indicate that somatic mutation had accumulated during
the extensive clonal expansion of sIgM2IgD1CD381 GC
B cells. The broad intraclonal diversification of clone
4b.1 and clone 6c.1, which accumulated 126 and 155
independent mutations and more than 30 different
amino acid replacements, respectively (many in CDRs;Figure 2. PCR Products of VH5-m, VH5-d, and VH5-g on Ethidium
Figure 5; Table 1), makes their IgV regions unlikely toBromide±Stained Agarose Gel
bind the same immunogen. In addition, replacementsIgD1CD382 naive B cells and sIgD1CD381 B cells only express m
mutations are not predominantly focused within CDRsand d transcripts, while sIgD2CD382 GC B cells only express m and
g transcripts. (see Figures 3 and 4; Figure 5; Table 2). For example,
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Figure 3. VH5-d Sequences from sIgD1CD382 Naive B Cells, sIgD1CD381 GC B cells, and the VH5-g Sequences from sIgD2CD381 GC B Cells
The upper and lower groups of sequences represent two different tonsils. Mutations are represented by replacement mutation (closed circle
with stem), silent mutation (stem), and hot spot of somatic mutation (open circle with stem). Each line represents one VH5 sequence. VH5-2
sequences are underlined. Sequences 4b and 4b9 derive from two independent reverse transcriptions and PCRs of the same RNA sample.
Clonally related sequences are boxed. Mutations present in the DJH regions are not shown. 39 Cd regions are unmutated.
Figure 4. VH5-d Sequences from sIgM2sIgD1CD381 GC B Cells and from sIgM2sIgD1 Peripheral Blood B Cells
sIgD1CD381 B cells from a third tonsil were separated into sIgM1 and sIgM2 subsets. The VH5-d sequences from the sIgM1 subset are either
in germline or low mutated (data not shown). The VH5-d sequences from the sIgM2 subset are shown in the right panel. sIgM2IgD1 B cells
were isolated from two peripheral blood samples. Their VH5-d sequences are shown in the left panel. The method for sequencing is detailed
in Pascual et al. (1994).
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Figure 5. Sequence Analysis of the Two Largest Hypermutated Clones
(A and B) Nucleotide sequences of hypermutated VH5-d clone 4b.1 and clone 6c.1.
(C) Genealogical trees from clone 4b.1 and clone 6c.1. The germline VH5±D±JH sequence (GL) was deduced from the consensus sequence for
each clone. Clonal trees were drawn so as to minimize the number of parallel mutations. Each analyzed sequence is indicated by its circled
number, while common predicted intermediates are boxed. The length of each line is proportional to the number of mutations (indicated in
the figure) that separate two connected sequences.
(Figure 5 continued on next page)
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hypermutated centroblasts was more difficult to induce
than for any other B cell subset. In general, the DNA
synthesis induced in these cells reached only 20%±30%
of that induced in sIgM1IgD1CD381 GC B cells (Figure
7). Presently, optimal growth conditions are obtained
with a combination of CD40 ligand-transfected L cells
(Banchereau et al., 1994), human synovial fibroblasts,
interleukin-10 (IL-10), and supernatant from activated
CD41 T cells (see Figure 6f; Figure 7). Such culture con-
ditions may indeed partially mimic the GC dark zone
microenvironment.
sIgM2IgD1CD381 Are Mainly Localized
within the Dark Zone of GCs
The anatomical distribution of sIgM2IgD1CD381 cells
was analyzed by immunohistology. Anti-IgD staining
(red) shows that while the majority of tonsillar GCs dothe ratio of the independent mutations in CDRs versus
not contain IgD1 B cells (Figure 8d), a few contain manyframeworks of the VH5±D±JH sequences from the two
large IgD1 cells that are mainly concentrated in the darklarge clones (4b.1 and 6c.1) is 0.58 (130/178), which is
zones (Figure 8a). Further double stainings with red anti-close to the length ratio between CDRs and frame-
IgD plus blue anti-CD38 (Figure 8b), blue anti-Ki67 (Fig-works (0.72).
ure 8c), and blue anti-IgM (Figures 8e and 8f) demon-
strate that the large IgD1 B cells in the GC dark zoneHypermutated sIgM2IgD1CD381 B Cells Do Not
express the GC B cell marker CD38, the GC centroblastMature into Circulating Memory B Cells
marker Ki67, and do not express IgM, a phenotype con-We then determined whether these IgM2IgD1CD381
sistent with the flow cytometry analysis. Therefore,hypermutated cells could mature into circulating mem-
these immunohistological data indicate that the isolatedory B cells. Most of the peripheral blood B cells express
hypermutated sIgM2IgD1CD381Ki671 large cells aresIgM and sIgD (90%). However, about 2%±5% of cells
derived from the GC dark zones.can be either sIgM1IgD2 or sIgM2IgD1. We obtained 17
VH5-d sequences from IgM2IgD1 B cells from two adult
Discussionperipheral blood donors (see Figure 4, right). Their muta-
tion frequency was only 0.8/100 bp. Among 17 se-
In the present study, we have identified a peculiar popu-quences, 5 contained 3±4 mutations and 1 contained
lation of tonsillar centroblasts that displays six striking18 mutations. The mutation frequency was even lower
features: first, the sole expression of sIgD isotype; sec-in 31 VH5-d sequences from sIgM1sIgD1 B cells of the
ond, the presence of the highest number of mutationssame samples (data not shown). Thus, the sIgM2
ever reported on IgVH region genes; third, an impressivesIgD1CD381 hypermutated centroblasts appear to be
clonal relatedness; fourth, morphology, phenotype, andsequestered within GCs.
location identical to those of GC centroblasts; fifth, in-
ability to mature into circulating memory B cells; andIsolated sIgM2IgD1CD381 B Cells Display
sixth, propensity to undergo apoptosis.
Morphology and Cell Cycle Status
Several lines of evidence indicate that the mutations
of Centroblasts and Are Difficult to Grow In Vitro found within VH5-d transcripts correspond to bonafide
In contrast with the small dense sIgD1CD382 naive B somatic mutations within the same polymerase chain
cells (Figure 6a), sIgM2sIgD1CD381 hypermutated GC B reaction (PCR) reaction, both germline and heavily mu-
cells display typical centroblast morphology (Figure 6b) tated VH5-d sequences were obtained; the regular distri-
and express the proliferation-associated nuclear anti- bution of mutations along the entire VDJ sequences can
gen Ki67, a centroblast marker (Figure 6c). After a 16 hr not be derived from reverse-transcription (RT) or PCR
culture, over 90% of sIgD1CD381 GC B cells from both artifacts such as conversion-like event; only six muta-
sIgM2 (Figure 6d) and sIgM1 subsets (data not shown) tions were found in the first 100 bp of 32 Cd region (0.18/
became apoptotic. In vitro growth of sIgM2sIgD1CD381 100 bp), which is close to the frequency of Taq error;
several mutations had accumulated in the JH genes seg-
ment (i.e., nine mutations in clone 4b.1 and four in clone
Table 1. Number of Amino Acid Differences Within the VH5±D±JH 6c.1). A detailed analysis of the nucleotide substitution
and the Heavy Chain CDRs (in parentheses) Between
pattern from the two largest hypermutated clones (4b.1Members of Clone 6c, as Deduced from their Nucleotide
and 6c.1) shows the characteristics of in vivo somaticSequences
mutations previously described, including an excess of
Clone transitions versus transversions (1.46/1) and a biased
number 6c1 3 7 9 10 distribution of mutations among the 4 nt of the coding
6c1 Ð 34 (13) 36 (15) 11 (5) 9 (2) strand (34% of the mutations affect a G, 27% affect an
3 Ð 38 (19) 35 (13) 33 (11) A, 28% affect a C, and 12% affect a T), which indicates
7 Ð 33 (15) 32 (11) a DNA strand preference (Betz et al., 1993; Chang and
9 Ð 9 (2) Casali, 1994; Lebecque and Gearhart, 1990; Neuberger
10 Ð
and Milstein, 1994; Reynaud et al., 1995; Insel and Var-
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Table 2. Antibody List
Anti-human antibodies Clone Isotype Source
CD2 (FITC) 39 C 1.5 IgG2a (rat) Immunotech
CD3 (FITC) UCHT 1 IgG1 Immunotech
CD10±FITC W8 E37 IgG2a Becton-Dickinson
CD14±FITC RMO 52 IgG2a Immunotech
CD19±FITC J4-119 IgG1 Immunotech
CD20±FITC IOB 20b IgG1 Immunotech
CD23±PE B-G6 IgG1 Serotec
CD38 T 10 IgG1 Immunotech
CD38±PE HB-7 IgG1 Becton-Dickinson
CD39 (Biotin) AC-2 IgG1 B.D.S.
CD44±FITC NaM 10-8F4 IgG1 Diagast
CD71±FITC IOA 71 IgG1 Immunotech
CD77 supernatant 38-13 IgM (rat) Immunotech
FAS±FITC UB 2 IgG1 Immunotech
FAS CH 11 IgM Immunotech
Bcl2±FITC IgG1 Dako
Ki67±FITC IgG1 Dako
IgM±FITC F(ab9)2 (rabbit) Dako
Ig D Biotin IgG (goat) Amersham
Ig A purified IgG1 Serotec
Ig G purified IgG1 Serotec
Secondary antibody
Goat anti-mouse±FITC IgG 1 IgM Bioart
Goat anti-rat±FITC IgM Nordic
Streptavidin±PE Becton-Dickinson
Streptavidin±FITC Immunotech
Streptavidin±Tricolor Caltag
Immunoglobulin isotype controls
mouse IgG1 Biotin Caltag
mouse IgM Immunotech
rat IgG2a FITC Immunotech
mouse IgG1 FITC/PE Immunotech
mouse IgG2a FITC/PE Immunotech
Immunochemistry
IgD Biotin IgG (goat) Amersham
IgM 145-8 IgGl Becton-Dickinson
CD 38 T 10 IgG1 Immunotech
Ki67±FITC IgG1 Dako
Streptavidin±Peroxydase Dako
APAAP Dako
ade, 1994); and the existence of mutational hot spots. trees, indicating that somatic mutations had been accu-
mulated during the clonal expansion of sIg-Among the 11 hypermutated (>10 mutations) and clon-
ally independent VH5-1 genes from clones 4b.1 and 6c.1, M2IgD1CD381 GC B cells.
According to the current estimated maximal rate ofall had mutation at position Ser31II, the major mutation
hot spot previously reported in this gene (Betz et al., somatic mutation (1 3 1023 per base pair per generation)
(Betz et al., 1993), a sIgM2IgD1 CD381 GC B cell must1993; van der Stoep et al., 1993). Moreover, minor muta-
tion hotspots were also found, as Ser28II, Gly54II, Ser77II, undergo 120 divisions in order to accumulate 40 muta-
tions. Assuming a 6 hr cell cycle time (Liu et al., 1991),Ser77III, and Met93II were mutated in 9, 6, 8, 6, and 6
independent VH5-1 sequences, respectively. the clone must remain for at least 720 hr within GCs.
Such a prolonged clonal expansion may explain why:Additional evidence further indicates that the highly
mutated VH5-d sequences really derive from the VH5 first, 18 of 31 hypermutated d sequences derived from
the estimated 1.5 3 106 IgM2IgD1CD381 VH51 GC B cellsgermline IgV genes, since they do not show higher ho-
mology to other genes than the two VH5 genes in the are clonally related; second, we observed occasionally
some GCs packed with IgD1CD381 Ki671 B cells. Inter-databank; the hypermutated VH5 genes seem to be a
specific feature of the sIgM2IgD1CD381 tonsillar B cells, estingly, we were unable to find such hypermutated
sIgD-only expressing cells in blood, suggesting thatas over 400 VH5 genes in association with either Cm or
Cg from other B cell subsets of 15 human tonsils and these cellseither die very rapidly within GCsor differenti-
ate into tonsillar IgD-only secreting plasma cells (C. A.three peripheral blood lymphocytes in our hands (Pas-
cual et al., 1994; unpublished data) do not contain hyper- et al., unpublished data).
The mechanism overactivating the somatic mutationmutated VH5 genes similar to the VH5-Cd genes; five
independent hypermutated VH5-Cd clones (clones 5.1, machinery in these cells seems to be related to their
sIgM2IgD1 phenotype. These cells could have under-5.3, 4b.1, 4b.3, and 6c.1) were identified in the present
study, being unlikely that they represent five new germ- gone Cm deletion, by homologous recombination be-
tween sm and Sd sequences (Yasui et al., 1989; Yuanline IgV genes. In addition, they form five separate clonal
Hypermutated IgD1 Germinal Center Cells
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Figure 6. Morphological Characterization of B Cell Subsets
(a) Giemsa staining of freshly isolated IgD1CD382 small dense naive B cells.
(b) Giemsa staining of freshly isolated IgM2IgD1CD381 large cells, displaying pyroninophilic scanty cytoplasm and blastic nuclear with multiple
nucleoli, typical of centroblast morphology.
(c) Red anti-Ki67 staining showing sIgM2IgD1CD381 GC B cells expressing a high level of Ki67 antigen, a centroblast marker.
(d) Giemsa staining of sIgM2IgD1CD381 GC B cells after 16 hr culture, displaying apoptotic figures. Hypermutated sIgM2IgD1CD381 GC cells
(5 3 105) were cultured for 5 days with (e) CD40 ligand-transfected L cells; (f) CD40 ligand-transfected L cells, human fibroblasts from
rheumatoid synovium, IL-10, and culture supernatant from human CD41 T cells activated with anti-CD2, anti-CD28, and PMA for 8 hr. (Culture
conditions are detailed in Figure 7.)
Immunity
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Figure 7. DNA Synthesis by sIgM1IgD1
CD381 and sIgM2IgD1CD381 GC B Cells
Cells (2.5 3 105/ml) were cultured for 5 days
in different conditions. IL-2 (10 U/ml), IL-4 (50
U/ml), IL-10 (100 ng/ml), 50% supernatant
from human peripheral blood CD41 T cells
activated for 8 hr with anti-CD2, anti-CD28,
and PMA, 2.5 3 104 CD40 ligand-transfected
L cells, and 2.5 3 103 human fibroblasts from
rheumatoid synovium (irradiated with 75 Gy)
were used for the cultures. DNA synthesis
was assessed by a 8 hr pulse with 1 mCi
[3H]TdR before cell harvesting.
Isolation of Tonsillar B Cellset al., 1985; Kluin et al., 1996). This event could have
Tonsil B cells were prepared as previously described (Liu et al.,removed both the switching region (Sm) required for
1995). In brief, tonsils taken from patients during routine tonsillec-further isotype switch, leading to constitutive expres-
tomy were finely minced and the resulting cell suspension was sub-
sion of sIgD in the absence of IgM, and a putative si- jected to two rounds of depletion of non-B cells: first, T cells were
lencer for somatic mutation that may becontained within depleted by rosetting sheep red blood cells; second, the residual
this region. In this context, it will be interesting to deter- non-B cells were depleted by T cell±specific antibodies (CD2, CD3,
mine the mutation status of the light chain genes of CD4) followed by magnetic beads coupled with anti-mouse IgG
(Dynabeads, Dynal, Oslo). The resulting cells from all the experi-these cells.
ments contain more than 98% CD191 B cells.The broad intraclonal diversification of clones 4b.1
and 6c.1 makes their IgV regions unlikely to bind the
Isolation of IgD1CD382 Naive B Cells (Bm11Bm2),same immunogen. This, together with the extensive re-
IgD2CD381 GC B Cells (Bm31Bm4), IgD2CD382 Memoryplacement mutations in the frameworks, suggests that
B Cells (Bm5), and IgD1CD381 Novel B Cell Subsets
the IgV regions are no longer under the classical antigen- Total tonsillar B cells at a concentration of 10 3 106/ml are incubated
driven selection. However, many bacterial antigens with anti-IgD±fluorescein isothiocyanate (FITC) and anti-CD38±
(Forsgren and Grubb, 1979), in particular the IgD-binding phycoerythrin (PE) in phosphate-buffered saline (PBS) containing
protein D from Haemophilus influenzae B (Janson et 2% bovine serum albumin (BSA) (PBS±BSA) for 30 min. Then cells
are washed twice and suspended in PBS at a concentration of 3 3al., 1991), one of the common human pathogens, may
106/ml. The four B cell subsets are separately sorted into a 15 mltrigger these B cells through the IgD±Fc region. Alterna-
Falcon tube containing RPMI 1640 medium supplemented with 10%tively, sIgD may be triggered by Fcd receptors on T
fetal calf serum. Two rounds of cell sorting are carried out to reachhelper cells, a T cell subset known to enhance humoral
over 98% purity.
immune responses (Coico et al., 1985, 1988). Triggering
sIgD only or sIgD together with sIgM seems to have Phenotype Analysis of the Four B Cell Subsets Defined
different effects on B cells, as sIgM but not sIgD is by the Expression of sIgD and sCD38
associated with prohibitin and a prohibitin-related pro- by Three-Color Immunofluorescence Flow Cytometry
tein that transduce negative cellular signals (Terashima Total tonsillar B cells are incubated with mouse anti-human CD38±
PE, goat anti-human IgD±biotin, anda set of FITC-conjugated mouseet al., 1994). It is possible that the appearance of sIgM2
anti-human molecules (IgM, CD23, CD44, CD10, CD71, CD77,IgD1 hypermutated centroblasts is the consequence of
Bcl-2, and Fas/CD95) for 20 min at 48C. After washing twice withconstitutive positive signaling through sIgD antigen re-
PBS containing 0.5% fetal calf serum and 2 mM sodium azide, theceptors, possibly by bacterial antigens, FcdR1 T cells,
cells are incubated with streptavidin±tricolor for 30 min. Then cells
or both. Germane to this hypothesis is the observation were ready to be analyzed with a FACScan flow cytometer. For
that IgD-deficient mice are more sensitive to tolerance intracellular Bcl-2 and nuclear Ki67 staining, cells were permeabil-
induction (Carsetti et al., 1993) and display a delay in ized by incubation with 0.3 mg/ml saponin for 15 min at 48C.
affinity maturation during T cell±dependent antibody re-
Separation of IgD1CD381 Tonsillar B Cells into IgM1sponses (Roes and Rajewsky, 1993). In conclusion, we
and IgM2 Subsets by Three-Colorhave isolated a population of sIgM2IgD1 centroblasts
Immunofluorescence FACS Sortingthat display remarkable proliferation and mutation ca-
Total tonsillar B cells are incubated with mouse anti-human CD38±pacities. These cells represent an important target for
PE, goat anti-human IgD±biotin, and mouse anti-human IgM±FITC
further investigation of GC development and molecular for 20 min at 48C. After washing twice with PBS containing 0.5%
characterization of the somatic mutation machinery. fetal calf serum and 2 mM sodium azide, the cells are incubated
with streptavidin±tricolor for 30 min. Then cells are washed twice
and suspended in PBS at concentration of 3 3 106/ml. IgD1CD381
B cells are separated into two subsets according to the expressionExperimental Procedures
of sIgM.
Antibodies
The details for the antibodies (clone number, isotype, and source) Giemsa Staining, and Analysis of Nuclear Antigen Ki67
used for phenotyping and immunomagnetic bead depletion are Cells (105) from each of the purified B cell subsets were cytocentri-
fuged for 5 min at 500 rpm on a microscope slide. Slides were fixedlisted in Table 2.
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Figure 8. Localization of IgM2IgD1CD381 GC B Cells in Tonsil Sections
(a) Red anti-IgD staining showing a red IgD1 mantle zone (FM) and a GC of a secondary follicle. Some IgD1 B cells are identified within the
GC, mainly in the dark zone. Original magnification, 1003.
(b) Double anti-IgD (red) and anti-CD38 (blue) staining on an adjacent section, showing IgD1CD381 B cells in the GC dark zone shown in (a).
Original magnification, 2003.
(c) Double anti-IgD (red) and anti-Ki67 (blue) staining of the same GC dark zone (original magnification, 2003). Nearly all IgD1 B cells within
the GC dark zone are Ki671, in contrast with the IgD1 B cells in the mantle zone (data not shown) and extrafollicular areas.
(d) A GC does not contain IgD1 B cells. Original magnification, 1003.
(e) Red anti-IgD and blue anti-IgM staining showing small purple IgM1IgD1 follicular mantle B cells; blue IgM immune complexes within the
GC light zone; and many large red IgM2IgD1 B cells in the GC dark zone. Original magnification, 1003.
(f) The GC dark zone shown in (e) at an original magnification of 2003, showing small purple IgM1IgD1 B cells and large red IgM2IgD1 B cells.
in methanol for 5 min and then stained with Giemsa staining solution bated with mouse monoclonal antibody against alkaline phospha-
tase and alkaline phosphatase complexes (APAAP) (DAKO). After(BDH Limited, Poole, England) diluted one in five with distilled water.
Some slides were fixed in cold acetone for 10 min at 48C for immuno- another 45 min, the slides were washed three times in PBS and the
enzyme activity was developed by the FAST RED substrate (DAKO).cytology. Slides were washed in PBS for 5 min and incubated with
mouse monoclonal antibodies against Ki67 antigen (DAKO, Glos-
trup, Denmark) for 45 min. The slides were washed twice in PBS Cell Cultures
Cells were cultured in RPMI 1640 medium containing 10% heat-and then incubated with sheep anti-mouse immunoglobulin (BDS,
Birmingham, England). After 45 min, slides were washed and incu- inactivated fetal calf serum, 80 mg/ml gentamicine and 2 mM gluta-
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mine (all from Flow Laboratories, McLean, Virginia) at 378C. Cells Betz, A.G., Neuberger, M.S., and Milstein, C. (1993). Discriminating
intrinsic and antigen-selected mutational hotspots in immunoglobu-(2.5 3 105/ml) were cultured for 5 days in different conditions. IL-2
(10 U/ml), IL-4 (50 U/ml), IL-10 (100 ng/ml), supernatant from human lin V genes. Immunol. Today 14, 405±411.
peripheral blood CD41 T cells cultured for 48 hr with anti-CD2, anti- Carsetti, R., KoÈhler, G., and Lamers, M.C. (1993). A role for immuno-
CD28, and PMA, 2.5 3 103 CD40 ligand-transfected L cells, and 2.5 globulin D: interference with tolerance induction. Eur. J. Immunol.
3 103 human fibroblasts from rheumatoid synovium (irradiated with 23, 168±178.
75 Gy) were used for the cultures. DNA synthesis was assessed by
Chang, B., and Casali, P. (1994). The CDR1 sequences of a majora 8 hr pulse with 1 mCi [3H]TdR before cell harvesting.
proportion of human germline Ig VH genes are inherently susceptible
to amino acid replacement. Immunol. Today 15, 367±372.
Immunohistology
Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNAPortions of tonsils were snap frozen in liquid nitrogen and stored
isolation by acid guanidium thiocyanate±phenol±chloroform extrac-at 2708C. Frozen sections (5 mm) were cut and mounted on glass
tion. Anal. Biochem. 162, 156±159.slides. They were thoroughly dried at room temperature for at least
Coffman, R.L., Lebman, D.A., and Rothman, P. (1993). Mechanism1 hr and were fixed in acetone at 48C for 15 min. Sections were
and regulation of immunoglobulin isotype switching. Adv. Immunol.stained by double immunoenzyme technique using the biotin±
54, 229±270.avidin±peroxidase system and the alkaline phosphatase±anti-alka-
line phosphatase system (APAAP technique). In brief, sections were Coico, R.F., Xue, B., Wallace, D., Pernis, B., Siskind, G.W., and
washed in PBS for 5 min. Then sections were incubated with goat Thorbecke, G.J. (1985). T cells with receptors for IgD. Nature 316,
anti-human IgD±biotin and mouse anti-human IgM or CD38 or Ki67 744.
(IgG1 isotype; Table 2). Following washing for 5 min in PBS, the Coico, R.F., Siskind, G.W., and Thorbecke, G.J. (1988). Role of IgD
sections were incubated with streptavidine±peroxidase and sheep and Td cells in the regulation of the humoral immune response.
anti-mouse IgG1 for 30 min, followed by incubation with alkaline Immunol. Rev. 105, 45±67.
phosphatase coupled to mouse antibodies specific for alkaline
Feuillard, J., Taylor, D., Casamayor-Palleja, M., Johnson, G.D., andphosphatase (APAAPcomplexes, DAKO, A/S, Denmark). After a final
MacLennan, I.C.M. (1995). Isolation and characteristics of tonsilwashing, peroxidase was developed by 3-amino-9-ethylcarbazole
centroblasts with reference to Ig class switching. Int. Immunol. 7,(Sigma), which gives a red color, and alkaline phosphatase was
121±130.developed by Fast blue substrate (Sigma), which gives a blue color
Forsgren, A., and Grubb, A.O. (1979). Many bacterial species bind(Liu et al., 1988).
human IgD. J. Immunol. 122, 1468±1472.
Gray, D. (1993). Immunological memory. Annu. Rev. Immunol. 11,Analysis of the VH5 Transcripts PCR Amplified
from the Human B Cell Subsets 49±77.
mRNA was extracted from 25 3 103 B cells according to Chomczyn- Insel, R.A., and Varade, W.S. (1994). Bias in somatic hypermutation
ski and Sacchi (1987). cDNA was obtained by reverse transcription, of human VH genes. Int. Immunol. 6, 1437±1443.
using the Superscript Reverse Transcriptase Kit (catalog 20898,
Jacob, J., Kelsoe, G., Rajewsky, K., and Weiss, U. (1991a). Intraclo-
BRL, Gaithersburg, Maryland), with oligo dT12±18 primers (catalog nal generation of antibody mutants in germinal centres. Nature 354,
27.7858-01, Pharmacia, Upsalla, Sweden). Full-length VH5-d tran- 389±392.
scripts wereamplified with 59 LVH5 primer (59-CCCGAATTCATGGGG
Jacob, J., Kassir, R., and Kelsoe, G. (1991b). In situ studies of theTCAACCGCCATCCT-39), with 39 primer HCd (59-GGCGGCCGCTGG
primary immune response to (4-hydroxy-3-nitrophenyl) acetyl. I. TheCCAGCGGAAGATCTCCTTCTT-39), HCm (TGGGGCGGATGCACTC
architecture and dynamics of responding cell populations. J. Exp.CC), or HCg (CAGGGGAAGACCGATGG) with Taq polymerase
Med. 173, 1165±1175.(Perkin Elmer Cetus, Norwalk, Connecticut) using the reaction buffer
provided by the manufacturers and a DNA Thermal cycler (Perkin Janson, H., Heden, L.O., Grubb, A., Ruan, M.R., and Forsgren, A.
Elmer Cetus) with 35 cycles of 1 min denaturation at 948C, 2 min of (1991). Protein D, an immunoglobulin D-binding protein or Haemo-
primer annealing at 608C, and 3 min extension at 728C. After the philus influenzae: cloning, nucleotide sequence, and expression in
last cycle, the reaction mixtures were incubated for 10 min at 728C Escherichia coli. Infect. Immun. 59, 119±125.
to ensure complete extension of all products. The PCR products Klein, U., KuÈppers, R., and Rajewsky, K. (1994). Variable region
were cloned in PCR II vector, using the TA Cloning Kit (Invitrogen). gene analysis of B cell subsets derived from a 4-year-old child:
Both DNA strands of plasmid extracted from individual bacterial somatically mutated memory B cells accumulate in the peripheral
colonies were sequenced using 221M13, M13RP, and HCd primers blood already at young age. J. Exp. Med. 180, 1383±1393.
on an automated DNA sequencer (Applied Biosystems, Incorpo-
Kluin, P.M., Kayano, H., Zani, V.J., Kluin-Nelemans, H.C., Tucker,rated). Sequencing was done with the 221M13 and M13RP primers
P.W., Satterwhite, E., and Dyer, M.J.S. (1996). IgD class switching:flanking the plasmid cloning sites, and with the HCd primer annealing
identification of a novel recombination site in neoplastic and normalwith the 39 end of CH1-d; VH5-Cg transcripts were amplified with B cells. Eur. J. Immunol. 25, 3504±3508.LVH5 and HCg primers, cloned, and sequenced using the 221M13
Kraal, G., Weissman, I.L., and Butcher, E.C. (1982). Germinal centreand M13RP primers only.
B cells: antigen specificity and charges in heavy chain class expres-
sion. Nature 298, 377±379.Acknowledgments
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